Alkem Labs shares give up gains after Malta regulatory audit ends with major and minor inspections

Alkem Laboratories told the exchanges on Wednesday, December 10, that the Malta Medicines Authority carried out a GMP inspection at its Daman manufacturing facility between December 5 and December 9.

The inspection wrapped up on December 9, 2025, with no critical observations, three major observations and a few minor ones.



The company said it will address these observations within the stipulated timeline for closure.

Shares of Alkem Laboratories Ltd. are currently trading 0.071% lower on Wednesday at ₹5,663.50. The stock is up just 2% so far in 2025.